Literature DB >> 26975230

The CYP2D6 VCF Translator.

W Qiao1, J Wang1,2, B S Pullman3, R Chen1,2, Y Yang1, S A Scott1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26975230      PMCID: PMC5025353          DOI: 10.1038/tpj.2016.14

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


× No keyword cloud information.
  10 in total

1.  An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people.

Authors:  Matthew R Nelson; Daniel Wegmann; Margaret G Ehm; Darren Kessner; Pamela St Jean; Claudio Verzilli; Judong Shen; Zhengzheng Tang; Silviu-Alin Bacanu; Dana Fraser; Liling Warren; Jennifer Aponte; Matthew Zawistowski; Xiao Liu; Hao Zhang; Yong Zhang; Jun Li; Yun Li; Li Li; Peter Woollard; Simon Topp; Matthew D Hall; Keith Nangle; Jun Wang; Gonçalo Abecasis; Lon R Cardon; Sebastian Zöllner; John C Whittaker; Stephanie L Chissoe; John Novembre; Vincent Mooser
Journal:  Science       Date:  2012-05-17       Impact factor: 47.728

Review 2.  Complexities of CYP2D6 gene analysis and interpretation.

Authors:  Andrea Gaedigk
Journal:  Int Rev Psychiatry       Date:  2013-10

Review 3.  Suggestions for the nomenclature of human alleles: relevance to ecogenetics, pharmacogenetics and molecular epidemiology.

Authors:  D W Nebert
Journal:  Pharmacogenetics       Date:  2000-06

4.  Quantifying rare, deleterious variation in 12 human cytochrome P450 drug-metabolism genes in a large-scale exome dataset.

Authors:  Adam S Gordon; Holly K Tabor; Andrew D Johnson; Beverly M Snively; Themistocles L Assimes; Paul L Auer; John P A Ioannidis; Ulrike Peters; Jennifer G Robinson; Lara E Sucheston; Danxin Wang; Nona Sotoodehnia; Jerome I Rotter; Bruce M Psaty; Rebecca D Jackson; David M Herrington; Christopher J O'Donnell; Alexander P Reiner; Stephen S Rich; Mark J Rieder; Michael J Bamshad; Deborah A Nickerson
Journal:  Hum Mol Genet       Date:  2013-11-26       Impact factor: 6.150

Review 5.  Cytochrome P450 2D6.

Authors:  Ryan P Owen; Katrin Sangkuhl; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2009-07       Impact factor: 2.089

6.  The star-allele nomenclature: retooling for translational genomics.

Authors:  J D Robarge; L Li; Z Desta; A Nguyen; D A Flockhart
Journal:  Clin Pharmacol Ther       Date:  2007-09       Impact factor: 6.875

7.  Identification of the primary gene defect at the cytochrome P450 CYP2D locus.

Authors:  A C Gough; J S Miles; N K Spurr; J E Moss; A Gaedigk; M Eichelbaum; C R Wolf
Journal:  Nature       Date:  1990-10-25       Impact factor: 49.962

8.  Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans.

Authors:  Roxana Daneshjou; Eric R Gamazon; Ben Burkley; Larisa H Cavallari; Julie A Johnson; Teri E Klein; Nita Limdi; Sara Hillenmeyer; Bethany Percha; Konrad J Karczewski; Taimour Langaee; Shitalben R Patel; Carlos D Bustamante; Russ B Altman; Minoli A Perera
Journal:  Blood       Date:  2014-07-30       Impact factor: 22.113

9.  Characterization of the common genetic defect in humans deficient in debrisoquine metabolism.

Authors:  F J Gonzalez; R C Skoda; S Kimura; M Umeno; U M Zanger; D W Nebert; H V Gelboin; J P Hardwick; U A Meyer
Journal:  Nature       Date:  1988-02-04       Impact factor: 49.962

10.  The Human Cytochrome P450 (CYP) Allele Nomenclature website: a peer-reviewed database of CYP variants and their associated effects.

Authors:  Sarah C Sim; Magnus Ingelman-Sundberg
Journal:  Hum Genomics       Date:  2010-04       Impact factor: 4.639

  10 in total
  6 in total

Review 1.  Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing.

Authors:  Yao Yang; Mariana R Botton; Erick R Scott; Stuart A Scott
Journal:  Pharmacogenomics       Date:  2017-05-04       Impact factor: 2.533

2.  Exploring the 1000 Genomes Project haplotype reporting for the CYP2D6 pharmacogene.

Authors:  Frank R Wendt; August E Woerner; Antti Sajantila; Rodrigo S Moura-Neto; Bruce Budowle
Journal:  Int J Legal Med       Date:  2018-06-02       Impact factor: 2.686

Review 3.  Institutional profile: translational pharmacogenomics at the Icahn School of Medicine at Mount Sinai.

Authors:  Stuart A Scott; Aniwaa Owusu Obeng; Mariana R Botton; Yao Yang; Erick R Scott; Stephen B Ellis; Richard Wallsten; Tom Kaszemacher; Xiang Zhou; Rong Chen; Paola Nicoletti; Hetanshi Naik; Eimear E Kenny; Aida Vega; Eva Waite; George A Diaz; Joel Dudley; Jonathan L Halperin; Lisa Edelmann; Andrew Kasarskis; Jean-Sébastien Hulot; Inga Peter; Erwin P Bottinger; Kurt Hirschhorn; Pamela Sklar; Judy H Cho; Robert J Desnick; Eric E Schadt
Journal:  Pharmacogenomics       Date:  2017-10-06       Impact factor: 2.533

Review 4.  PharmVar GeneFocus: CYP2D6.

Authors:  Charity Nofziger; Amy J Turner; Katrin Sangkuhl; Michelle Whirl-Carrillo; José A G Agúndez; John L Black; Henry M Dunnenberger; Gualberto Ruano; Martin A Kennedy; Michael S Phillips; Houda Hachad; Teri E Klein; Andrea Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2019-12-09       Impact factor: 6.875

Review 5.  Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy.

Authors:  Victoria M Pratt; Larisa H Cavallari; Andria L Del Tredici; Andrea Gaedigk; Houda Hachad; Yuan Ji; Lisa V Kalman; Reynold C Ly; Ann M Moyer; Stuart A Scott; R H N van Schaik; Michelle Whirl-Carrillo; Karen E Weck
Journal:  J Mol Diagn       Date:  2021-06-10       Impact factor: 5.341

6.  A systematic comparison of pharmacogene star allele calling bioinformatics algorithms: a focus on CYP2D6 genotyping.

Authors:  David Twesigomwe; Galen E B Wright; Britt I Drögemöller; Jorge da Rocha; Zané Lombard; Scott Hazelhurst
Journal:  NPJ Genom Med       Date:  2020-08-03       Impact factor: 8.617

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.